Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

The effects of low- and high-dose-rate brachytherapy on depressive symptoms in prostate cancer patients.

Sharpley CF, Christie DH, Bitsika V, Oar AJ.

Int J Clin Oncol. 2014 Dec;19(6):1080-4. doi: 10.1007/s10147-013-0647-1. Epub 2013 Dec 17.

PMID:
24343676
2.

Differences in major depressive disorder and generalised anxiety disorder symptomatology between prostate cancer patients receiving hormone therapy and those who are not.

Sharpley CF, Bitsika V, Wootten AC, Christie DR.

Psychooncology. 2014 Dec;23(12):1350-5. doi: 10.1002/pon.3566. Epub 2014 Apr 30.

PMID:
24789575
3.

A single institutional experience with definitive radiotherapy for cervical cancer using both high- and low-dose-rate brachytherapy.

Gerszten K, Gooding WE, Lin Y, Heron DE, Faul C.

Gynecol Oncol. 2006 Sep;102(3):500-7. Epub 2006 Feb 28.

PMID:
16503346
4.

Do prostate cancer patients suffer more from depressed mood or anhedonia?

Sharpley CF, Bitsika V, Christie DH.

Psychooncology. 2013 Aug;22(8):1718-23. doi: 10.1002/pon.3203. Epub 2012 Sep 27.

PMID:
23019092
5.

Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes.

Chen CP, Weinberg V, Shinohara K, Roach M 3rd, Nash M, Gottschalk A, Chang AJ, Hsu IC.

Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):324-9. doi: 10.1016/j.ijrobp.2013.01.027. Epub 2013 Mar 6.

PMID:
23474112
6.

A prospective dose escalation trial of high-dose-rate brachytherapy boost for prostate cancer: Evidence of hypofractionation efficacy?

Tang JI, Williams SG, Tai KH, Dean J, Duchesne GM.

Brachytherapy. 2006 Oct-Dec;5(4):256-61.

PMID:
17118320
7.

High-dose rate brachytherapy compared with open radical prostatectomy for the treatment of high-risk prostate cancer: 10 year biochemical freedom from relapse.

Savdie R, Symons J, Spernat D, Yuen C, Pe Benito RA, Haynes AM, Matthews J, Rasiah KK, Jagavkar RS, Yu C, Fogarty G, Kattan MW, Brenner P, Sutherland RL, Stricker PD.

BJU Int. 2012 Dec;110 Suppl 4:71-6. doi: 10.1111/j.1464-410X.2012.11480.x.

8.

Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs external beam radiation therapy alone for prostate cancer.

Khor R, Duchesne G, Tai KH, Foroudi F, Chander S, Van Dyk S, Garth M, Williams S.

Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):679-85. doi: 10.1016/j.ijrobp.2012.07.006. Epub 2012 Sep 3.

PMID:
22954770
9.

Prevalence and association of somatic symptoms in patients with Major Depressive Disorder.

Vaccarino AL, Sills TL, Evans KR, Kalali AH.

J Affect Disord. 2008 Oct;110(3):270-6. doi: 10.1016/j.jad.2008.01.009. Epub 2008 Feb 15.

PMID:
18280580
10.

Alternative diagnostic criteria for major depressive disorder in patients with chronic pain.

Wilson KG, Mikail SF, D'Eon JL, Minns JE.

Pain. 2001 Apr;91(3):227-34.

PMID:
11275378
11.

Depression and major depressive disorder in patients with Parkinson's disease.

Inoue T, Kitagawa M, Tanaka T, Nakagawa S, Koyama T.

Mov Disord. 2010 Jan 15;25(1):44-9. doi: 10.1002/mds.22921.

PMID:
20014057
12.

External beam radiotherapy plus single-fraction high dose rate brachytherapy in the treatment of locally advanced prostate cancer.

Boladeras A, Santorsa L, Gutierrez C, Martinez E, Pera J, Pino F, Suarez JF, Ferrer F, Díaz A, Polo A, Guedea F.

Radiother Oncol. 2014 Aug;112(2):227-32. doi: 10.1016/j.radonc.2014.07.013. Epub 2014 Aug 28.

PMID:
25174299
13.

Measuring depression in prostate cancer patients: does the scale used make a difference?

Sharpley CF, Bitsika V, Christie DR, Hunter MS.

Eur J Cancer Care (Engl). 2017 Jan;26(1). doi: 10.1111/ecc.12393. Epub 2015 Oct 2.

PMID:
26428948
14.

Are somatic symptoms a legitimate part of the depression profile in prostate cancer patients?.

Sharpley CF, Bitsika V, Christie DH.

Onkologie. 2013;36(3):110-4. doi: 10.1159/000348531. Epub 2013 Feb 21.

PMID:
23485998
15.

The prevalence and severity of depressive symptoms along the spectrum of unipolar depressive disorders: a post hoc analysis.

Rakofsky JJ, Schettler PJ, Kinkead BL, Frank E, Judd LL, Kupfer DJ, Rush AJ, Thase ME, Yonkers KA, Rapaport MH.

J Clin Psychiatry. 2013 Nov;74(11):1084-91. doi: 10.4088/JCP.12m08194.

PMID:
24330894
16.

Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiation therapy in the treatment of intermediate-risk prostate cancer - long term results.

Cury FL, Duclos M, Aprikian A, Patrocinio H, Kassouf W, Shenouda G, Faria S, David M, Souhami L.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1417-23. doi: 10.1016/j.ijrobp.2011.05.025. Epub 2011 Jul 23.

PMID:
21784585
17.

Prostate-specific antigen bounce after high-dose-rate prostate brachytherapy and hypofractionated external beam radiotherapy.

Patel N, Souhami L, Mansure JJ, Duclos M, Aprikian A, Faria S, David M, Cury FL.

Brachytherapy. 2014 Sep-Oct;13(5):450-5. doi: 10.1016/j.brachy.2014.05.005. Epub 2014 Jul 10.

PMID:
25023396
18.

Diagnosing 'male' depression in men diagnosed with prostate cancer: the next step in effective translational psycho-oncology interventions?

Sharpley CF, Bitsika V, Christie DR.

Psychooncology. 2014 Sep;23(9):1042-8. doi: 10.1002/pon.3530. Epub 2014 Apr 3.

PMID:
24700681
19.

Treatment of localized prostate cancer using a combination of high dose rate Iridium-192 brachytherapy and external beam irradiation: initial Australian experience.

Stevens MJ, Stricker PD, Saalfeld J, Brenner PC, Kooner R, O'Neill GF, Duval PJ, Jagavkar RS, Cross P, Martland J.

Australas Radiol. 2003 Jun;47(2):152-60.

PMID:
12780444
20.

Radiotherapy alone for invasive vaginal cancer: outcome with intracavitary high dose rate brachytherapy versus conventional low dose rate brachytherapy.

Kucera H, Mock U, Knocke TH, Kucera E, Pötter R.

Acta Obstet Gynecol Scand. 2001 Apr;80(4):355-60.

PMID:
11264612

Supplemental Content

Support Center